Business Context and Reporting Period
This Form 8-K filing by The Clorox Company (CLOROX CO) was submitted on May 23, 2018, reporting a corporate governance event approved by the Board of Directors on the same date.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial metric disclosed is the authorization of a new share repurchase program with an aggregate purchase price of up to $2 billion.
Material Changes
- Share Repurchase Program Update: The Board terminated the previously announced share repurchase authorization from May 8, 2017.
- New Authorization: A new program was authorized allowing for the repurchase of shares up to $2 billion.
- Program Terms: The program has no time limit, is discretionary based on market conditions, and may be suspended or discontinued at any time.
- Evergreen Program: This new authorization is in addition to the existing evergreen repurchase program designed to offset dilution from stock incentive plan issuances.
Guidance, Outlook, and Risks
The filing contains no forward-looking financial guidance, management commentary on operational outlook, or discussion of specific risks and contingencies beyond the standard disclosure that the repurchase program does not obligate the Company to make any purchases.
Investor Verification Checklist
- Verify the termination of the May 8, 2017, share repurchase authorization.
- Confirm the $2 billion aggregate limit of the new repurchase program.
- Review the Company's existing evergreen program for dilution offset to understand total potential buyback capacity.
- Monitor future filings for actual repurchase activity and share counts.